AFT Pharmaceuticals said it was “pleased” to deliver double digit growth across all regions following another year of restrictions, curveballs and headwinds.
The listed Auckland-based drug manufacturer released its full-year results ending March 31 this morning, and despite ongoing Covid
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
